Literature DB >> 3588995

Dose-volume analysis and the prevention of radiation sequelae in cervical cancer.

J M Crook, B A Esche, G Chaplain, J Isturiz, I Sentenac, J C Horiot.   

Abstract

We report a 9 year (1975-1983) experience of treatment of carcinoma of the uterine cervix by radiation alone. Computerized dosimetry conforming to the ICRU 38 recommendations was performed for all 348 patients analyzed. Late sequelae were graded as mild (grade 1), moderate (grade 2) and severe (grade 3). The overall rates were grade 3: 9.8%, grade 2: 18%, and grade 1: 19.5%. Of the moderate to severe sequelae, 48% were rectal, 15% rectosigmoid and 21% urinary. The complication rate was highly dependent on the type of intracavitary applicator: lowest for patients treated by two insertions of a standard Fletcher-Suit applicator (grade 3: 5.4%, grade 2: 14.4%) and highest for those receiving uterine stem plus vaginal line sources (grade 3: 29.5%, grade 2: 26%). For 183 patients treated with stem and standard ovoids, moderate and severe rectal and bladder sequelae were analyzed according to critical organ reference doses and reference treatment volumes as defined by ICRU 38, with the addition of a mean rectal dose. Zones of low, moderate and high risk could be defined on dose-volume plots using these parameters. Modification of treatment plans at the Cancer Institute G. F. Leclerc (CGFL) of Dijon according to these concepts produced a reduction in moderate and severe sequelae (grade 3: 14.4-3.4%) without a concurrent increase in pelvic failures. Although the zones of risk proposed can be used directly only with standard Fletcher-Suit applicators and comparable computer dosimetry, the concept can be applied to other systems.

Entities:  

Mesh:

Year:  1987        PMID: 3588995     DOI: 10.1016/s0167-8140(87)80182-2

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

1.  [Dosimetry methods in determining radiation dosage of the rectum in HDR-brachytherapy of cervix carcinoma].

Authors:  H T Eich; U Haverkamp; O Micke; F J Prott; R Pötter
Journal:  Strahlenther Onkol       Date:  1998-07       Impact factor: 3.621

2.  Comparison of manual and inverse optimisation techniques in high dose rate intracavitary brachytherapy of cervical cancer: A dosimetric study.

Authors:  Ram Abhinav Kannan; Janaki Manur Gururajachar; Arul Ponni; Kirthi Koushik; Mohan Kumar; Ram Charith Alva; Ritika Harjani; Arvind Murthy
Journal:  Rep Pract Oncol Radiother       Date:  2015-06-26

3.  Influence of brachytherapy applicators geometry on dose distribution in cervical cancer.

Authors:  E Senkus-Konefka; A Kobierska; J Jassem; K Serkies; A Badzio
Journal:  Strahlenther Onkol       Date:  1997-06       Impact factor: 4.033

4.  Optimal bladder filling during high-dose-rate intracavitary brachytherapy for cervical cancer: a dosimetric study.

Authors:  Umesh Mahantshetty; Saurabha Shetty; Dipanjan Majumder; Pranjal Adurkar; Jamema Swamidas; Reena Engineer; Supriya Chopra; Shyamkishore Shrivastava
Journal:  J Contemp Brachytherapy       Date:  2017-04-30

5.  Inverse planning for combination of intracavitary and interstitial brachytherapy for locally advanced cervical cancer.

Authors:  Kotaro Yoshio; Naoya Murakami; Madoka Morota; Ken Harada; Mayuka Kitaguchi; Kentaro Yamagishi; Shuhei Sekii; Kana Takahashi; Koji Inaba; Hiroshi Mayahara; Yoshinori Ito; Minako Sumi; Susumu Kanazawa; Jun Itami
Journal:  J Radiat Res       Date:  2013-05-31       Impact factor: 2.724

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.